High Efficacy of Dupilumab in Omalizumab-Refractory Severe Chronic Spontaneous Urticaria and Delayed Pressure Urticaria

被引：0
|
作者：
Pastor-Nieto, M. A. [1 ,2 ,3 ,4 ,5 ]
Gatica-Ortega, M. E. [4 ]
机构：
[1] Hosp Univ Fdn Jimenez Diaz, Serv Dermatol, Madrid, Spain
[2] Hosp Univ Guadalajara, Serv Dermatol, Guadalajara, Madrid, Spain
[3] Univ Alcala, Fac Med & Ciencias Salud, Dept Med & Especial Med, Alcala De Henares, Spain
[4] Univ Castilla La Mancha, Albacete, Spain
[5] Complejo Hospitalario Univ Toledo, Serv Dermatol, Toledo, Spain
来源：
ACTAS DERMO-SIFILIOGRAFICAS | 2025年 / 116卷 / 02期
关键词：
D O I：
10.1016/j.ad.2023.07.038
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：191 / 193
页数：3
相关论文
共 50 条
  • [41] The efficacy of omalizumab therapy in chronic spontaneous urticaria: A retrospective analysis
    Turkmen, Meltem
    Coban, Melis
    Dogan, Sinan
    Uygur, Fatma
    Soylu, Ibrahim Hakki
    TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY, 2019, 53 (02): : 65 - 67
  • [42] Efficacy of omalizumab treatment for patients with chronic idiopathic urticaria (CIU)/chronic spontaneous urticaria (CSU) in Taiwan
    Yan, Che-Wen
    Cho, Yung-Tsu
    Chu, Chia-Yu
    DERMATOLOGICA SINICA, 2017, 35 (04) : 182 - 186
  • [43] Severe chronic sponta- neous urticaria successfully treated with omalizumab and dupilumab
    Puxkandl, V.
    Hoetzenecker, W.
    Altrichter, S.
    ALLERGOLOGIE, 2023, 46 (01) : 70 - 73
  • [44] Efficacy and rapid activity of omalizumab retreatment in chronic spontaneous urticaria
    Nettis, Eustachio
    Di Leo, Elisabetta
    Foti, Caterina
    Cegolon, Luca
    Vacca, Angelo
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 78 (06) : 1211 - 1213
  • [45] Effectiveness of omalizumab in a series of 114 patients with refractory chronic spontaneous urticaria
    Labrador-Horrillo, M.
    Valero, A.
    Velasco, M.
    Jauregui, I
    Sastre, J.
    Bartra, J.
    Silvestre, J. F.
    Ortiz de Frutos, J.
    Gimenez-Arnau, A.
    Ferrer, M.
    ALLERGY, 2013, 68 : 603 - 604
  • [46] The efficacy and safety of omalizumab in refractory chronic spontaneous urticaria: real-life experience in Turkey
    Bulur, Isil
    Baskan, Emel Bulbul
    Ozdemir, Mustafa
    Balevi, Ali
    Goncu, Emek Kocaturk
    Altunay, Ilknur
    Gonul, Muzeyyen
    Ergin, Can
    Ertam, Ilgen
    Erdogan, Hilal Kaya
    Bilgin, Muzaffer
    Erdem, Mustafa Teoman
    ACTA DERMATOVENEROLOGICA ALPINA PANNONICA ET ADRIATICA, 2018, 27 (03): : 121 - 126
  • [47] Efficacy and safety of omalizumab in Chinese patients with anti-histamine refractory chronic spontaneous urticaria
    Yuan, Weiru
    Hu, Shuling
    Li, Min
    Yang, Lijia
    Liu, Lingling
    Zheng, Min
    Guo, Zaipei
    Song, Zhiqiang
    Zhang, Chunlei
    Diao, Qingchun
    Xu, Jinhua
    Richard, Alexia
    Patwardhan, Moreshwar
    Lyu, Tianmeng
    Uddin, Alkaz
    Fogel, Robert
    Ligueros-Saylan, Monica
    Zheng, Jie
    DERMATOLOGIC THERAPY, 2022, 35 (04)
  • [48] Effectiveness of sirolimus in severe refractory chronic spontaneous urticaria
    Patel, Gaytri
    Khan, David A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2024, 12 (06): : 1663 - 1665
  • [49] Two Cases of Severe Refractory Chronic Idiopathic Urticaria Treated with Omalizumab
    Vestergaard, Christian
    Deleuran, Mette
    ACTA DERMATO-VENEREOLOGICA, 2010, 90 (04) : 443 - 444
  • [50] Omalizumab, a therapeutic option for delayed pressure urticaria
    Hernandez, Noelia
    Liuti, Federica
    Hernandez, Javier
    Borrego, Leopoldo
    Penate, Yeray
    Hernandez, Zaida
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (04) : AB59 - AB59
12345